THUMPD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.870600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.884600E-01
Normal-vs-Stage2
3.795800E-01
Normal-vs-Stage3
7.945900E-02
Normal-vs-Stage4
7.750800E-01
Stage1-vs-Stage2
3.226200E-01
Stage1-vs-Stage3
1.306440E-02
Stage1-vs-Stage4
5.665200E-01
Stage2-vs-Stage3
4.300400E-02
Stage2-vs-Stage4
9.549700E-02
Stage3-vs-Stage4
1.004420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.705000E-01
Normal-vs-AfricanAmerican
8.169800E-01
Normal-vs-Asian
3.392800E-01
Caucasian-vs-AfricanAmerican
4.471400E-01
Caucasian-vs-Asian
5.290600E-01
AfricanAmerican-vs-Asian
3.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.623600E-01
Normal-vs-Female
4.383200E-01
Male-vs-Female
5.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.302800E-01
Normal-vs-Age(41-60Yrs)
5.544000E-01
Normal-vs-Age(61-80Yrs)
3.493000E-01
Normal-vs-Age(81-100Yrs)
3.108000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.375000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.260200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.883800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.688830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.086600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.327020E-01
Normal-vs-Daily Drinker
1.560410E-01
Normal-vs-Weekly Drinker
3.424800E-01
Normal-vs-Occasional Drinker
6.266800E-01
Normal-vs-Social Drinker
4.647600E-01
Non Drinker-vs-Daily Drinker
8.419200E-01
Non Drinker-vs-Weekly Drinker
8.218000E-01
Non Drinker-vs-Occasional Drinker
1.367240E-01
Non Drinker-vs-Social Drinker
1.606020E-01
Daily Drinker-vs-Weekly Drinker
7.347600E-01
Daily Drinker-vs-Occasional Drinker
1.451420E-01
Daily Drinker-vs-Social Drinker
1.588380E-01
Weekly Drinker-vs-Occasional Drinker
3.799200E-01
Weekly Drinker-vs-Social Drinker
4.212200E-01
Occasional Drinker-vs-Social Drinker
8.560400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.212000E-02
Normal-vs-Grade 2
3.902800E-03
Normal-vs-Grade 3
2.501200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.448000E-01
Grade 1-vs-Grade 3
1.962200E-01
Grade 1-vs-Grade 4
3.212000E-02
Grade 2-vs-Grade 3
7.406000E-01
Grade 2-vs-Grade 4
3.902800E-03
Grade 3-vs-Grade 4
2.501200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.317000E-01
Normal-vs-NonDiabetic
2.924400E-01
Diabetic-vs-NonDiabetic
3.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.721980E-01
Normal-vs-NoPancreatitis
3.133000E-01
Pancreatitis-vs-NoPancreatitis
5.613000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.035000E-01
Normal-vs-N1
4.119600E-01
N0-vs-N1
5.587400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.104200E-01
Normal-vs-TP53-NonMutant
7.802400E-01
TP53-Mutant-vs-TP53-NonMutant
8.033800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
